Multiplex organoid mutagenesis reveals gene combinations driving transformation, pathology, and chemosensitivity in ovarian carcinoma
GENETICS · 2026
DOI: 10.1093/genetics/iyag098 ↗Kurz gefasst
Fachartikel in der Zeitschrift GENETICS, 2026. Verfasst von Daryl J Phuong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine, 618 Tower Rd, Ithaca, NY 14853, United State…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Organoids, Mutagenesis, Cell Transformation, Neoplastic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: NCI NIH HHS, NIH HHS, Ovarian Cancer Research.
Abstract (Originalsprache)
High-grade serous ovarian carcinoma (HGSC) is the sixth leading cause of cancer-related death among women. Most tumors arise from the Fallopian tubal epithelium (TE), exhibit numerous mutations, and present heterogenous pathological features. However, the contribution of specific mutation combinations to cellular transformation, pathological phenotype, and chemotherapeutic responses remains unclear. We used a mouse TE organoid platform for combinatorial CRISPR mutagenesis of 20 candidate HGSC driver genes. Besides Trp53, mutations in Nf1, Cdkn2a, and Map2k4 were the most prevalent in phenotypically transformed organoids. Map2k4 mutant organoids transplanted into mice predominantly yielded papillary-glandular carcinomas, whereas those with Nf1 mutations were more mesenchymal-like. Map2k4 mutant cells were particularly sensitive to paclitaxel, and Rho kinase inhibitor (ROCKi) increased trametinib sensitivity in both Map2k4- and Nf1-mutant organoids. This organoid mutagenesis strategy is powerful for unraveling the genetic and phenotypic complexity of HGSC, and identified Map2k4 as a potential therapeutic target in select HGSC cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Translational Sciences, Cornell University, College of Veterinary Medicine, 618 Tower Rd, Ithaca, NY 14853, United States.
- Department of Molecular Biology and Genetics, Cornell University, College of Agriculture and Life Sciences, Ithaca, NY 14853, United States.
- Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853, United States.
ORCID-Profile: Daryl J Phuong, Coulter Q Ralston, Andrea Flesken-Nikitin, John C Schimenti
Förderung
- NCI NIH HHS
- NIH HHS
- Ovarian Cancer Research
- Sandra Atlas Bass Endowment for Cancer Research
- Graduate Research Fellowship Program
- NSF
- NIH
Zitieren
APA
Phuong, D. J., Ralston, C. Q., Ezzat, T. M., Ashe, C. S., Armstrong, A. P., Flesken-Nikitin, A., Yamulla, R. J., Nikitin, A. Y., & Schimenti, J. C. (2026). Multiplex organoid mutagenesis reveals gene combinations driving transformation, pathology, and chemosensitivity in ovarian carcinoma. GENETICS. https://doi.org/10.1093/genetics/iyag098
Vancouver
Phuong DJ, Ralston CQ, Ezzat TM, Ashe CS, Armstrong AP, Flesken-Nikitin A, et al. Multiplex organoid mutagenesis reveals gene combinations driving transformation, pathology, and chemosensitivity in ovarian carcinoma. GENETICS. 2026. doi:10.1093/genetics/iyag098
BibTeX
@article{Phuong2026,
author = {Phuong, Daryl J and Ralston, Coulter Q and Ezzat, Tony M and Ashe, Christopher S and Armstrong, Amanda P and Flesken-Nikitin, Andrea and Yamulla, Robert J and Nikitin, Alexander Yu and Schimenti, John C},
title = {Multiplex organoid mutagenesis reveals gene combinations driving transformation, pathology, and chemosensitivity in ovarian carcinoma},
journal = {GENETICS},
year = {2026},
doi = {10.1093/genetics/iyag098}
}
EUVIMED